Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Kappa Opioid Receptor Imaging in Post-traumatic Stress Disorder (PTSD)

NCT02237703 is registered in ClinicalTrials.gov with NYU Langone Health as lead sponsor.

NCT NCT02237703
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02237703 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Kappa Opioid Receptor Imaging in Post-traumatic Stress Disorder (PTSD)
Lead sponsor
NYU Langone Health
Phase
Observational
Overall status
Terminated
Start date
March 31, 2012
Completion date
August 31, 2016
Enrollment
17 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

post-traumatic stress disorder (ptsd), trauma